EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

A Perspective on Current Flavivirus Vaccine Development: A Brief Review

Sudip Kumar Dutta iD, Thomas Langenburg

Viruses · 2023

DOI: 10.3390/v15040860 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Viruses, 2023. Verfasst von Sudip Kumar Dutta und 1 weiteren Autor:innen. Beteiligte Einrichtung: Artemis Bioservices, Molengraaffsingel 10, 2629 JD Delft, The Netherlands. Hauptthemen laut MEDLINE: Flavivirus, Viral Vaccines, Flavivirus Infections, Yellow Fever. Die Arbeit wurde bisher 67-mal zitiert (Crossref) und nennt 130 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The flavivirus genus contains several clinically important pathogens that account for tremendous global suffering. Primarily transmitted by mosquitos or ticks, these viruses can cause severe and potentially fatal diseases ranging from hemorrhagic fevers to encephalitis. The extensive global burden is predominantly caused by six flaviviruses: dengue, Zika, West Nile, yellow fever, Japanese encephalitis and tick-borne encephalitis. Several vaccines have been developed, and many more are currently being tested in clinical trials. However, flavivirus vaccine development is still confronted with many shortcomings and challenges. With the use of the existing literature, we have studied these hurdles as well as the signs of progress made in flavivirus vaccinology in the context of future development strategies. Moreover, all current licensed and phase-trial flavivirus vaccines have been gathered and discussed based on their vaccine type. Furthermore, potentially relevant vaccine types without any candidates in clinical testing are explored in this review as well. Over the past decades, several modern vaccine types have expanded the field of vaccinology, potentially providing alternative solutions for flavivirus vaccines. These vaccine types offer different development strategies as opposed to traditional vaccines. The included vaccine types were live-attenuated, inactivated, subunit, VLPs, viral vector-based, epitope-based, DNA and mRNA vaccines. Each vaccine type offers different advantages, some more suitable for flaviviruses than others. Additional studies are needed to overcome the barriers currently faced by flavivirus vaccine development, but many potential solutions are currently being explored.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FlavivirusViral VaccinesFlavivirus InfectionsYellow FeverZika VirusZika Virus InfectionAnimalsHumansMosquito Vectors

Stichwörter der Autor:innen

Japanese encephalitis and tick-borne encephalitisWest NileZikaclinical trialsdengueflavivirusvaccinesyellow fever

Substanzen

Viral Vaccines

Autor:innen und Institutionen

  • Artemis Bioservices, Molengraaffsingel 10, 2629 JD Delft, The Netherlands.

ORCID-Profile: Sudip Kumar Dutta

Zitieren

APA

Dutta, S. K., & Langenburg, T. (2023). A Perspective on Current Flavivirus Vaccine Development: A Brief Review. Viruses. https://doi.org/10.3390/v15040860

Vancouver

Dutta SK, Langenburg T. A Perspective on Current Flavivirus Vaccine Development: A Brief Review. Viruses. 2023. doi:10.3390/v15040860

BibTeX
@article{Dutta2023,
  author = {Dutta, Sudip Kumar and Langenburg, Thomas},
  title = {A Perspective on Current Flavivirus Vaccine Development: A Brief Review},
  journal = {Viruses},
  year = {2023},
  doi = {10.3390/v15040860}
}
Kostenlos starten →